Peter D Binstock, MD
Infectious Disease · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Binstock’s office at (925) 947-2334 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G48118 · Current
Licensed to practise in California · since 1982 · expires 2028-04-30 · University of Oklahoma College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Infectious Disease
- American Board of Internal Medicine - Internal Medicine
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 21 Part D prescriptions in 2023. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2023 | 21 | None | 0% (0) | None | $294 |
| 2022 | 24 | None | 0% (0) | None | $174 |
| 2021 | 32 | None | 0% (0) | None | $1,934 |
| 2020 | 33 | None | 0% (0) | 0% | $1,001 |
| 2019 | 12 | None | 0% (0) | None | $134 |
| 2017 | 59 | 14 | 0% (0) | 32% | $28,484 |
| 2016 | 342 | 62 | None | 49% | $749,297 |
| 2015 | 277 | 52 | None | 54% | $527,835 |
| 2014 | 252 | 39 | 0% (0) | 52% | $303,482 |
| 2013 | 219 | 40 | None | 54% | $126,132 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2016: 9 drugs
| Harvoni | 13 | $410,438 | $31,572 |
| Truvada | 34 | $49,290 | $1,450 |
| Prezista | 22 | $29,084 | $1,322 |
| Tivicay | 12 | $17,293 | $1,441 |
| Norvir | 26 | $9,626 | $370 |
| Doxycycline Hyclate | 13 | $1,238 | $95 |
| Rifampin | 11 | $580 | $53 |
| Cephalexin | 22 | $453 | $21 |
| Sulfamethoxazole-Trimethoprim | 18 | $51 | $3 |
2015: 6 drugs
| Truvada | 29 | $41,462 | $1,430 |
| Prezista | 23 | $28,782 | $1,251 |
| Norvir | 30 | $12,917 | $431 |
| Rifabutin | 12 | $9,146 | $762 |
| Ethambutol | 12 | $1,033 | $86 |
| Sulfamethoxazole-Trimethoprim | 11 | $62 | $6 |
2014: 9 drugs
| Truvada | 28 | $43,253 | $1,545 |
| Reyataz | 12 | $20,592 | $1,716 |
| Prezista | 13 | $15,352 | $1,181 |
| Norvir | 30 | $13,965 | $465 |
| Vancomycin | 11 | $3,180 | $289 |
| Cefuroxime | 14 | $1,720 | $123 |
| Ethambutol | 14 | $1,578 | $113 |
| Rifampin | 12 | $800 | $67 |
| Azithromycin | 12 | $414 | $35 |
2013: 8 drugs
| Truvada | 28 | $34,648 | $1,237 |
| Reyataz | 12 | $17,275 | $1,440 |
| Baraclude | 12 | $12,555 | $1,046 |
| Norvir | 21 | $12,477 | $594 |
| Vancomycin | 11 | $4,230 | $385 |
| Ethambutol | 12 | $827 | $69 |
| Cefuroxime | 11 | $384 | $35 |
| Minocycline | 12 | $232 | $19 |
Professional record
- NPI
- 1487686838
- Licence
- CA G48118California G48118: Current · expires 2028-04-30
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G481180
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 365 Lennon Ln, Ste 200, Walnut Creek, CA, 94598
- NPI first listed
- 2006-07-07
- NPI last updated
- 2017-02-21
This is when the NPI record was last certified, not a medical board exam.